Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1864663 (
HCC
)
2,985
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
MiRNAs, as oncogenes or as anti-oncogenes, play critically regulated roles in human cancers at posttranscriptional level. A number of dysregulated miRNAs has been observed in
HCC
. However, the expression and function of miR-670-5p have not been evaluated in
HCC
to date. In this study, we examined and confirmed the over-expression of miR-670-5p in
HCC
and in hepatoma-derived cells Hep3B. At least 60% of
HCC
tissues showed a greater than three-fold enhance in the expression of miR-670-5p compared with paired adjacent non-cancerous tissues. Knockdown studies for miR-670-5p showed that the expression of miR-670-5p promoted cellular proliferation. In tissues and cells with high expression of miR-670-5p, decreased expression of
PROX1
, a miR-670-5p predicated target, was detected. It confirmed that
PROX1
expression was obviously affected by the expression of miR-670-5p. Furthermore, overexpression of
PROX1
greatly inhibitted cellular proliferation. Therefore, it was inferred that miR-670-5p may play important roles in enhancing proliferation activity that is associated with
HCC
by modulating
PROX1
expression at posttranscriptional level.
...
PMID:MiR-670-5p induces cell proliferation in hepatocellular carcinoma by targeting PROX1. 2679 60